Cymbalta approved for diabetic peripheral neuropathy pain
446718
The US Food and Drug Administration has approved Eli Lilly&#39;s Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor.
518023
WASHINGTON -- The popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures.
585106
Pfizer Inc. won U.S. approval on Thursday to promote its prescription drug Lyrica for treating fibromyalgia, a chronic disease which can cause debilitating pain, sleep problems, stiffness and fatigue.
576693
For people with type 2 diabetes  and moderately elevated blood glucose levels, the medication  vildagliptin, sold under the brand name Galvus, can produce  long-term improvements in the functioning of the  insulin-secreting beta cells in the pancreas along with better  glucose control, researchers report.
220150
MONDAY, July 9 (HealthDay News) -- The Exelon skin patch (rivastigmine transdermal system) has been approved by the U.S. Food and Drug Administration to treat dementia associated with mild-to-moderate Alzheimer&#39;s disease, maker Novartis Pharmaceuticals said Monday.
723411
NEW YORK  - People with diabetes often  suffer from chronic and sometimes severe pain, and this can  create difficulties for them in the management of their  condition and with self-care activities, researchers have  found.
248369
Diabetes patients could soon be able to take a pill to control their condition instead of repeated injections.
733890
NEW YORK, NOVEMBER 25: The Federal Government has just approved a new medicine for multiple sclerosis that doctors say represents a new treatment approach that will significantly reduce the frequency of disabling episodes.
608329
TUESDAY, Feb. 13 (HealthDay News) -- Adding fuel to the debate over medical marijuana, a new study suggests that AIDS patients can relieve stubborn nerve pain in their feet by smoking the drug.
514256
UK scientists have worked out a vaccine to stop Type-1 Diabetes for those with pre-disposition or recent diagonosis. The first human trial of the vaccine will start next year.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
440447
The US Food and Drug Administration has approved Purdue Pharma&#39;s Palladone (hydromorphone hydrochloride) for people requiring 24-hour pain relief for an extended period.
182690
Enhancing a natural pain-filtering mechanism in the spine helped relieve chronic pain in mice without the unwanted side effects of current pain relievers, Swiss researchers said on Wednesday.
388799
The US Food and Drug Administration (FDA) has approved Sepracor Inc.&#39;s (Nasdaq: SEPR) Lunesta brand eszopiclone, a prescription non-benzodiazepine, for the long-term treatment of insomnia.
163907
A new class of diabetes drugs touted by drugmakers was moderately effective in controlling blood sugar levels without adding extra weight, but more long-term data are needed before the drugs should be widely embraced, U.S. researchers said on Tuesday.
708447
NEW YORK  - For people with type 2 diabetes and moderately elevated blood glucose levels, the medication vildagliptin, sold under the brand name Galvus, can produce long-term improvements in the functioning of the insulin-secreting beta cells in the pancreas along with better glucose control, researchers report.
746041
The U.S. Food and Drug  Administration on Friday approved a new Purdue Pharma L.P.  opioid-based drug that aims to provide "around-the-clock"  relief to patients with moderate to severe pain.